356531-43-6

Basic information

• Product Name: N-(4-Fluorobenzyl)-4-Methoxyaniline, 97%
• Synonyms: N-(4-Fluorobenzyl)-4-Methoxyaniline, 97%;4-Ethoxy-N-(4-fluorobenzyl)aniline, 97%
• CAS NO: 356531-43-6
• Molecular Formula: C14H14FNO
• Molecular Weight: 231.2654632
• Mol File: 356531-43-6.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 353.2±27.0 °C(Predicted)
• Appearance: /
• Density: 1.169±0.06 g/cm3(Predicted)
• PKA: 4.54±0.25(Predicted)
• CAS DataBase Reference: N-(4-Fluorobenzyl)-4-Methoxyaniline, 97%(CAS DataBase Reference)
• NIST Chemistry Reference: N-(4-Fluorobenzyl)-4-Methoxyaniline, 97%(356531-43-6)
• EPA Substance Registry System: N-(4-Fluorobenzyl)-4-Methoxyaniline, 97%(356531-43-6)

Safety Data

• Hazardous Substances Data: 356531-43-6(Hazardous Substances Data)

Usage

Description

N-(4-Fluorobenzyl)-4-Methoxyaniline, 97% is an organic compound characterized by the presence of a fluorobenzyl group attached to an aniline molecule, which is further substituted with a methoxy group. N-(4-Fluorobenzyl)-4-Methoxyaniline, 97% is typically available in a purity of 97%, indicating a high level of purity and quality for various applications.

Uses

Used in Pharmaceutical Industry:
N-(4-Fluorobenzyl)-4-Methoxyaniline, 97% is used as an active pharmaceutical ingredient for the development of various drugs. Its unique structure allows it to interact with specific biological targets, making it a promising candidate for the treatment of different medical conditions.
Used in Anesthetics:
In the field of anesthesiology, ethers substituted with fluorine, such as N-(4-Fluorobenzyl)-4-Methoxyaniline, 97%, are employed as volatile anesthetics. These compounds provide effective anesthesia with minimal side effects, making them valuable in surgical procedures.
Used in Asthma Medications:
N-(4-Fluorobenzyl)-4-Methoxyaniline, 97% finds application as a propellant in metered-dose inhalers, which are used to administer some asthma medications. Its properties allow for efficient delivery of the medication to the lungs, providing relief for patients with asthma and other respiratory conditions.
Used in Cancer Treatment:
As part of the pharmaceutical industry, N-(4-Fluorobenzyl)-4-Methoxyaniline, 97% may also be used in the development of cancer treatments. Its specific interactions with biological targets can potentially lead to the development of new therapies for various types of cancer.
Used in Sedatives:
In the development of sedatives, N-(4-Fluorobenzyl)-4-Methoxyaniline, 97% may be utilized due to its potential to modulate the central nervous system. This application could contribute to the creation of new sedatives with improved efficacy and reduced side effects.
Overall, N-(4-Fluorobenzyl)-4-Methoxyaniline, 97% is a versatile compound with a wide range of applications in the pharmaceutical, anesthetic, and respiratory medication industries. Its unique structure and properties make it a valuable asset for the development of new drugs and therapies to improve human health.

Upstream product

• 64-17-5 ethanol 
• 39769-08-9 N-(4-fluorobenzylidene)-4-methoxyaniline 

Relevant articles and documents

NEW METHOD FOR THE SYNTHESIS OF UNSYMMETRICAL TERTIARY AMINES

Disclosed is a new method for the synthesis of unsymmetrical tertiary amines using alcohol and an imine, and to new tertiary amines.

CATALYST COMPOUNDS

The present invention relates to an iridium-based catalyst compound for hydrogenating reducible moieties, especially imines and iminiums, the catalyst compounds being defined by the formulas: where ring B is either itself polycyclic, or ring B together with R is polycyclic. The catalysts of the invention are particularly effective in reductive amination procedures 10 which involve the in situ generation of the imine or iminium under reductive hydrogenative conditions.